Pulmonary Arterial Hypertension Clinical Trials in Pittsburgh, Pennsylvania

4 studies are recruiting for pulmonary arterial hypertension in Pittsburgh, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

    Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow. This causes high blood pressure in the lungs and overworks the heart. PAH can make it hard to breathe and be active. Some standard (usual) tre…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    University of Pittsburgh Medical Center - Presbyterian Hosp. ( Site 1059), Pittsburgh, Pennsylvania
    Locations
    136 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT07218029 on ClinicalTrials.gov

  2. Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

    This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study

    Stage
    Phase 3
    Ages
    18 to 75
    Site
    UPMC Presbyterian Hospital, Pittsburgh, Pennsylvania
    Locations
    120 in total
    Run by
    Gossamer Bio USA, Inc.

    See if you can join NCT06274801 on ClinicalTrials.gov

  3. PET Image in PAH Patients

    Pulmonary arterial hypertension (PAH) is mortal disease affecting the blood vessels of the lung. Despite its morbid prognosis, PAH is often misdiagnosed or ignored, with an average time of 44 months between onset of symptoms to diagnosis and substantial progression of disease severity. Therefore, a…

    Stage
    EARLY_Phase 1
    Ages
    18 to 75
    Site
    Montefiore Hospital Clinical and Translational Research Center, Pittsburgh, Pennsylvania
    Run by
    Stephen Y. Chan

    See if you can join NCT05452889 on ClinicalTrials.gov

  4. Pulmonary Hypertension Association Registry

    The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people with PAH and CTEPH who are cared for in participating PHA-accredited Pulmonary Hypertension Care C…

    Stage
    Not phased
    Ages
    0 and older
    Site
    Allegheny General Hospital, Pittsburgh, Pennsylvania
    Locations
    52 in total
    Run by
    Pulmonary Hypertension Association, Inc.

    See if you can join NCT04071327 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.